This federal contract award, valued at $4,181.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Envarsus XR 4 mg tablets, a specialty medication, to support military healthcare programs globally.
The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal medical institutions. The contract encompasses critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The award was not designated with any set-aside requirements, indicating open competition.
Generated 3/27/25, 9:56 AM